Biofil Chemicals & Pharmaceuticals Limited (BIOFILCHEM) — FY26 Annual Report | 26 August 2026

26 August 2026 · NSE 🔴 High Importance Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

41st AGM convened via video conference on 23 September 2026

🔄 What Changed

Approval sought for continuation of Ashok Kumar Ramawat as director past age 75 and material related party transactions with Cyano Pharma up to INR 20 crores

🔮 What's Next

The company recommends approval of special resolution for Ramawat's continued directorship and ordinary resolution for Cyano Pharma transactions

💡 Investor Takeaway

Shareholders must approve key director appointments and related party deals that could impact financial performance

Biofil Chemicals & Pharmaceuticals Limited announced its 41st Annual General Meeting scheduled for 23 September 2026 via video conference. Shareholders will vote on adopting audited financial statements, appointing Smitesh Shah as a director, continuing Ashok Kumar Ramawat as an independent director past age 75, and approving material related party transactions with Cyano Pharma up to INR 20 crores. The meeting will be conducted electronically with remote e-voting and proxy voting dispensed. All resolutions require shareholder approval under SEBI and MCA regulations.

📄 View Original Announcement (PDF)

📊 Stock Analysis — BIOFILCHEM ✨ Ask AI About This

About Biofil Chemicals & Pharmaceuticals Limited (BIOFILCHEM)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹51.78 CrP/E: 106.1ROE: 2.2%ROCE: 3.3%

View full BIOFILCHEM stock details →

📡 Get AI alerts when BIOFILCHEM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track BIOFILCHEM — Free

💡 Ask AI about this filing

"What is the expected impact of Cyano Pharma transactions on FY27 profitability?""How does the company plan to maintain governance with Ramawat's continued directorship?""What is the current shareholding pattern of promoters post-AGM?"

Ask AI Free →

📊 More BIOFILCHEM filings

🟡 Board Meeting — 24 September 2026Biofil Chemicals announced the continuation of Mr. Ashok Kumar Ramawat as a Non-Executive Independen...
🟡 Voting Results — 24 September 2026At the 41st AGM on 23 September 2026, shareholders approved all four resolutions via remote e-voting...
Announcement — 24 September 2026Biofil Chemicals & Pharmaceuticals Ltd announced the closure of its insider trading window effective...
🟡 Board Meeting — 23 September 2026Biofil Chemicals held its 41st AGM on 23 September 2026 via video conference, confirming quorum and ...
🟡 Board Meeting — 11 August 2026Biofil Chemicals & Pharmaceuticals announced board approval of unaudited Q1 FY26 results showing rev...

See all BIOFILCHEM filings →

🔥 Also filed on 26 August 2026

ORIENTCEMOrient Cement LimitedCorporate Action IRBIRB Infrastructure Developers LimitedCorporate Action EUROTEXINDEurotex Industries and Exports LimitedAnnual Report INNOVISIONInnovision LimitedAnnouncement MOLDTECHMold-Tek Technologies LimitedCorporate Action MOTHERSONSamvardhana Motherson International LimitedCorporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when BIOFILCHEM files new disclosures

Track BIOFILCHEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.